Investing.com - Financial Markets Worldwide

Jefferies raises Invesco stock price target to $21 on QQQ announcement

Published 23/07/2025, 12:06
Jefferies raises Invesco stock price target to $21 on QQQ announcement
IVZ
1.77%

Investing.com - Jefferies maintained its Hold rating on Invesco (NYSE:IVZ) while raising its price target to $21.00 from $16.00 following the asset manager’s second-quarter 2025 results. The stock, currently trading at $21.25, is approaching its 52-week high of $21.68, having delivered an impressive 25.89% return in the past week. According to InvestingPro data, the company appears fairly valued at current levels.

The investment bank increased its 2025 earnings per share estimate slightly from $1.81 to $1.82, while making a more substantial revision to its 2026 EPS forecast, which rose from $2.00 to $2.23.

Jefferies attributed the larger 2026 estimate increase primarily to Invesco’s QQQ announcement, partially offset by expectations for a higher tax rate.

The firm noted that momentum across Invesco’s business is improving as the company continues to execute well on its strategy.

Despite the positive execution, Jefferies observed that fund flow trends still favor Invesco’s lower-fee product suite, which impacts the company’s revenue potential.

In other recent news, Invesco Plc reported its second-quarter 2025 earnings, showing a mixed financial performance. The company achieved a significant revenue increase, reaching $1.51 billion, surpassing the forecasted $1.1 billion by 37.27%. Despite this revenue success, Invesco’s earnings per share (EPS) fell short of expectations, coming in at $0.36 compared to the anticipated $0.40. These results highlight a strong revenue performance but also reveal challenges in meeting EPS projections. The earnings announcement has prompted a varied reaction from the market. Analysts may continue to assess the implications of these earnings results on Invesco’s future financial health. Investors will be watching closely for any further updates or insights from analyst firms regarding potential impacts on the company’s outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.